Endocrinology

Clifford Chirls discusses the features of the new social networking site iMedExchange and explains how it diff ers from other social networking resources for physicians.

Electronic prescribing is rapidly gaining support from a diverse array of healthcare organizations, government agencies, and technology corporations.

These three physicians decided to take the bull by the horns and start their own EHR companies.

There have already been some snags and alarms raised in questioning just how successful this new batch of tech toys for diabetes will be in the end.

The use of PTH as an enhancer to the body’s own bone-building mechanisms could lead to new drugs for treating osteoporosis.

Patients with type 2 diabetes mellitus gain added benefit if their exercise regimen included aerobic activities and eccentric resistance training.

A meta-analysis of 40 previously published studies conducted by Elizabeth Selvin, PhD, MPH, of the Johns Hopkins Bloomberg School of Public Health, and colleagues has found that treatment with the diabetes drug metformin may be associated with a lower risk of death from cardiovascular disease.

Howard Simon, MD, Director, Newly Invasive and Bariatric Surgery, State University Hospital Syracuse, discusses adrenal masses.

Nicole Artz, MD, a hospitalist and Assistant Professor of Medicine at the University of Chicago Hospital, discusses implications of hyperglycemia in hospitalized patients.

Two new studies point to parents' perception of weight being an important factor in a child's obesity.

Despite some caveats, the vast majority of people I know on insulin pumps are very happy with their control and flexibility.

Premature babies with hydrocortisone, which is believed to fight inflammation and prevent lung disease, has very little or no benefit at all.

The British Medical Journal concluded that their research does "not provide evidence to support the use of aspirin in primary prevention of cardiovascular events and mortality."

Dr. Rasheed Balogun discusses the risk factors and rising worldwide incidence rates of chronic kidney disease.

Dr. Jay Cohen, an endocrinologist, discusses thyroid disease. He reviews the difference between hypo and hyper thyroidism, as well as the treatment of hypothryoidism. Memphis, Tenn. Call 901-763-3636 for more information.

Many of us will see a big increase in the number of patients who are simply unable to afford their medications.

Early warning signs of gestational diabetes can be found within nine weeks of gestation.

Lower levels of cortisol have been linked to antisocial behavior among male adolescents.

For those of you involved in the world of diabetes, a glucometer that measures glucose without pain is the next most desirable piece of technology.

Researchers developed a prediction tool to estimate the benefit of adding androgen deprivation therapy.

Healthcare professionals are recommended by the American College of Physicians to consider drug treatment for patients at risk for bone fractures due to osteoporosis or low bone density.

Endocrinology is not known for being very heavy on anything "tech", aside from insulin pumps and CGMS (continuous glucose monitoring sensor) devices.

Diabetes prevention strategies and the needed lifestyle and diabetes changes for improved health are well-known.

Louise B. Andrew is a fifth-generation physician who has made a career of serving health professionals in distress after her own experience dealing with a medical malpractice suit.

Electronic Health Record (EHR) systems hold great promise. However, like many new technologies, the difficulty of achieving EHRs' promise has been vastly underestimated, as have the risks. The current national initiatives pushing for widespread EHR implementation may be leading us into an unmapped minefield.

Consider this hypothetical situation: A patient with new onset of a major depression is evaluated by a physician who has found no evidence of suicidal ideation.

Many physicians are skeptical about getting involved in the practice, and rightfully so. Sermo and other online physician communities are rife with posts and comments from physicians who know colleagues who have stretched the truth or even lied on the stand because of personal beliefs or compensation.

One of the most important legal documents in your practice may have a significant impact on your finances. And even though you (or someone in your practice) agreed to abide by its terms and conditions, it's highly likely that you have never even read it.

According to an article published in the June 17, 2008 edition of the New York Times, declining reimbursements, managed care, physician shortages (especially in primary care), and concerns about malpractice are contributing to doctors' discontent.

David Van Avermaete, CEO of VeraLight, a medical device company, discusses the SCOUT DS non-invasive diabetes screening system and the importance of early detection in type 2 diabetes.